Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 36, Issue 8 (Aug 1998)

Issues

Ethical and Legal Issues in the Procurement, Storage and Use of DNA

Matthew J. McQueen
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.093

Abstract

At the risk of ignoring the benefits, the problems of genetic testing have been widely discussed. Many clinical laboratories are archival stores for human tissues and very few have formal policies and procedures for the use of this material. There is little evidence of planning or preparation of appropriate protocols for the safekeeping of the collected clinical material. The process of informed consent needs to be re-examined. The standard of what would be expected by a reasonable and prudent person poses challenging questions relating to confidentiality and privacy, control and ownership of the stored tissue and cells, withdrawing from a research study, length of storage of samples, the use of biological materials by other parties, and the use of biological materials for purposes other than those for which they were first obtained. There also needs to be a clear understanding of identifiable, non-identifiable and anonymous samples. Clinical laboratory staff and their professional organisations need to engage in the discussion and development around the ethical, legal and social issues raised by testing human DNA. Clinical research laboratories will be increasingly involved in DNA testing and will be asked for access to stored blood or tissue. It is essential that professional responsibility is understood and is then exercised in the presence of appropriate policies and procedures. There is also a paramount need to involve the public who are already demonstrating evidence of alienation from the world occupied by genetics research.

About the article

Published Online: 2005-06-01

Published in Print: 1998-08-01



Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.093. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
David E. Bruns, Carl A. Burtis, Ann M. Gronowski, Matthew J. McQueen, Anthony Newman, and Jon J. Jonsson
Clinica Chimica Acta, 2015, Volume 442, Page 115
[2]
Klaus Hoeyer
Biotechnology and Genetic Engineering Reviews, 2008, Volume 25, Number 1, Page 429
[3]
Eric M. Meslin and Kimberly A. Quaid
Journal of Laboratory and Clinical Medicine, 2004, Volume 144, Number 5, Page 229
[4]
Elizabeth C Jazwinska
Drug Discovery Today, 2001, Volume 6, Number 4, Page 198
[5]
Klaus Hoeyer
Current Anthropology, 2005, Volume 46, Number S5, Page S71
[6]
Julia Balaguer, Adela Cañete, Elisa Costa, Silvestre Oltra, Miguel Hernández, and Victoria Castel
Clinical and Translational Oncology, 2006, Volume 8, Number 12, Page 884
[7]
Stefan-M. Pulst
Muscle & Nerve, 2000, Volume 23, Number 10, Page 1503

Comments (0)

Please log in or register to comment.
Log in